The	O
Acute	O
Dialysis	O
Quality	O
Initiative	O
-	O
-	O
part	O
IV	O
:	O
membranes	B-Multi-tissue_structure
for	O
CRRT	O
.	O

The	O
extracorporeal	B-Multi-tissue_structure
membrane	I-Multi-tissue_structure
used	O
in	O
a	O
continuous	O
renal	B-Organ
replacement	O
therapy	O
(	O
CRRT	O
)	O
for	O
the	O
treatment	O
of	O
a	O
critically	O
ill	O
patient	O
with	O
acute	O
renal	B-Organ
failure	O
(	O
ARF	O
)	O
is	O
vitally	O
important	O
for	O
several	O
reasons	O
,	O
including	O
its	O
influence	O
on	O
biocompatibility	O
and	O
filter	O
performance	O
.	O

The	O
clinical	O
relevance	O
of	O
membrane	B-Multi-tissue_structure
-	O
related	O
biocompatibility	O
markers	O
traditionally	O
used	O
in	O
chronic	O
hemodialysis	O
remains	O
unclear	O
in	O
CRRT	O
.	O

Numerous	O
approaches	O
may	O
be	O
used	O
to	O
assess	O
membrane	B-Multi-tissue_structure
and	O
filter	O
performance	O
in	O
CRRT	O
,	O
but	O
no	O
specific	O
methodology	O
is	O
accepted	O
widely	O
at	O
present	O
.	O

Although	O
a	O
potential	O
benefit	O
of	O
certain	O
membranes	B-Multi-tissue_structure
used	O
for	O
CRRT	O
is	O
adsorptive	O
removal	O
of	O
inflammatory	O
mediators	O
,	O
this	O
issue	O
has	O
not	O
been	O
assessed	O
carefully	O
in	O
well	O
-	O
designed	O
clinical	O
trials	O
.	O

These	O
and	O
other	O
issues	O
should	O
be	O
the	O
subject	O
of	O
future	O
clinical	O
research	O
efforts	O
.	O

